Use of Surfactant Preparations for the Treatment of Surgical Adhesions

1 - 6 . (canceled)

7 . A method for treating surgical adhesions in a patient in need thereof comprising the step of:

administering a surfactant preparation comprising at least one phospholipid, surfactant protein and optionally excipients to the patient in need thereof.

8 . The method according to claim 7 , wherein the surfactant preparation is administered topically.

9 . A pharmaceutical composition comprising a surfactant preparation suited for a method of claim 7 , wherein the surfactant preparation comprises at least one phospholipid, pulmonary surfactant proteins SP-B and/or SP-C and/or modified derivatives thereof, and optionally excipients.

10 . A commercial product comprising:

a customary secondary packaging,

a primary packaging comprising a pharmaceutical preparation of at least one phospholipid and surfactant protein SP-B and/or SP-C and, optionally,

a package insert,

the pharmaceutical preparation being suitable for treatment of surgical adhesions in patients in need thereof.

11 . A pharmaceutical composition comprising a surfactant preparation suited for the method of claim 8 , wherein the surfactant preparation comprises at least one phospholipid, pulmonary surfactant proteins SP-B and/or SP-C and/or modified derivatives thereof, and optionally excipients.

12 . The method according to claim 7 , wherein the surfactant protein is recombinantly prepared pulmonary surfactant protein.

13 . The method according to claim 7 , wherein the surfactant protein is a modified derivative of a pulmonary surfactant protein.

14 . The method according to claim 12 , wherein the pulmonary surfactant protein is rSP-C (FF/I).

15 . The method according to claim 7 , wherein the surfactant preparation is in the form of a powder.

16 . The method according to claim 15 , wherein the powder is obtainable by spray-drying.